Patients with HIV infections and the TT genotype may have decreased trough concentrations of lopinavir as compared to patients with the CC or CT genotypes. Note that this association was only found in patients of European descent, and not in African American or Hispanic patients. Other genetic and clinical factors may also affect concentrations of lopinavir in patients.